Research focusing on new targeting strategies for metastatic castration-resistant prostate cancer (mCRPC) is burgeoning, as reflected by the procee......READ MORE
An analysis shared at the 2022 Genitourinary Cancers Symposium highlights the importance of considering a patient's treatment preferences and quali......READ MORE
Data presented at the 2022 Genitourinary Cancers Symposium offer new insights into the utility of prostate-specific membrane antigen positron emiss......READ MORE
At the 2022 Genitourinary Cancers Symposium, several presentations highlighted the progress that has been made with targeted radioligand therapy fo......READ MORE
Data reported at the 2022 Genitourinary Cancers Symposium highlight disparities in prostate cancer care.Following these proceedings, featured exper......READ MORE
Data from the 2022 Genitourinary Cancers Symposium continue to shed light on the role of prostate cancer biomarkers in screening, staging, and trea......READ MORE